Introduction: Ventricular arrhythmia (VA) from the left ventricular summit (LVS) is a common origin of VA, which resulting LV dysfunction in some patients. However, the predictors of LV cardiomyopathy were not well-elucidated. The present study sought to investigate the risk factor of LV cardiomyopathy and the outcome in patients with LVS VA Methods: Between 2013 and 2018, a total of 139 patients (60.7% men; mean age 53.2 ± 13.9 years-old) underwent catheter ablation for LVS VA from two centers. Detailed patient demographics, electrocardiograms, electrophysiological characteristics, and clinical outcomes were extracted for analysis. LV cardiomyopathy was defined as LV ejection fraction (LVEF) <50%. Results: Acute procedural success was achieved in 92.8 % of patients. There were 40 patients (28.8%) with LV cardiomyopathy, and the mean LVEF improved from 37.5 ± 9.3% to 48.5 ± 10.2% after ablation ( p < 0.001). After multivariate analysis, the independent predictors of LV dysfunction were wider QRS duration of the VA (odds ratio [OR]1.02; 95% confidence interval [CI]: 1.00-1.04; p = 0.046) and the absolute earliest activation time discrepancy (AEAD) between epicardium and endocardium (OR 1.05; 95% confidence interval CI: 1.00-1.09; p = 0.048). After ablation, the LV function was completely recovered in 20 patients (50%). The predictors for irreclaimable LV function included wider PVC QRS duration (OR 1.09; 95% CI: 1.02-1.17; p = 0.012) and poorer LVEF (OR 0.85; 95% CI: 0.74-0.97; p = 0.020). Conclusion: In patients with VA from LVS, PVC QRS duration and AEAD predicted the deteriorating LV systolic function. Catheter ablation could reverse the LV remodeling. Narrower QRS duration and better LVEF predicted a better recovery of LV function after ablation.
Catheter ablation for tachyarrhythmia via superior approach has been used in patients without possible inferior vena cava access such as in cases of venous occlusion or complex anomaly. Difficulty in catheter manipulation, instability, number of required vascular access, and radiation exposure of operator had been described in the procedure. Application of three-dimensional (3-D) mapping system in catheter ablation via superior approach could navigate the guiding catheter and provide more precise ablation. We reported four cases receiving catheter ablation due to atrioventricular nodal reentry tachycardia, atrial fibrillation and right ventricular arrhythmia via superior approach facilitated by 3-D mapping system with fewer vascular access and catheters.
The health crisis due to coronavirus disease 2019 (COVID-19) shocks the world with more than million infections and casualties. COVID-19 could present from mild illness to multi-organ involvement, especially acute respiratory distress syndrome. Cardiac injury and arrhythmias including atrial fibrillation (AF) are not uncommon in COVID-19. COVID-19 is highly contagious, and the therapy against the virus remains premature and largely unknown. These make the management of AF patients during pandemic particularly challenging. We here describe possible pathophysiology link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.